Cullen Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Sell
11,647
-151
-1% -$154K 1.69% 16
2026
Q1
$10.9M Sell
11,798
-250
-2% -$253K 1.43% 15
2025
Q4
$12.8M Sell
12,048
-253
-2% -$242K 1.66% 13
2025
Q3
$10.3M Sell
12,301
-201
-2% -$150K 1.37% 18
2025
Q2
$9.75M Sell
12,502
-171
-1% -$133K 1.38% 19
2025
Q1
$10.5M Sell
12,673
-142
-1% -$118K 1.59% 15
2024
Q4
$9.89M Buy
12,815
+53
+0.4% +$43.9K 1.46% 17
2024
Q3
$11.3M Sell
12,762
-128
-1% -$115K 1.69% 11
2024
Q2
$11.7M Sell
12,890
-683
-5% -$546K 1.86% 11
2024
Q1
$10.4M Sell
13,573
-86
-0.6% -$61.2K 1.63% 15
2023
Q4
$7.96M Buy
+13,659
New +$7.97M 1.39% 17

Other funds holding LLY

Cullen Investment Group's LLY Position: Q2 2026 in Review

Cullen Investment Group reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $154K and leaving 11,647 shares worth $14M. The position accounts for 1.69% of the portfolio, ranked #16.

Cullen Investment Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cullen Investment Group held 11,647 shares of Eli Lilly worth $14M as of Q2 2026.
  • Cullen Investment Group sold 151 Eli Lilly shares in Q2 2026, an estimated $154K.
  • Eli Lilly made up 1.69% of Cullen Investment Group's portfolio in Q2 2026, its #16 holding.
  • Cullen Investment Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.